Molecular basis of the anti-inflammatory property exhibited by cyclo-pentano phenanthrenol isolated from Lippia nodiflora

Immunological Investigations

Volumn 39, Issue 7, 2010, Pages 713-739

  Balakrishnan, Gayathri ^a   Janakarajan, Lakshmi ^a   Balakrishnan, Arun ^b   Lakshmi, Baddireddi Subhadra ^a  

^a ANNA UNIVERSITY   (India)

^b Piramal Enterprises Limited   (India)

Author keywords

Arachidonic acid NF B; Lippa nodiflora; MAPK; NO

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; CYCLOPENTANONE DERIVATIVE; CYCLOPENTANOPHENANTHRENOL; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPPIA NODIFLORA EXTRACT; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGENIC AGENT; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IC 50; LIPPIA; LIPPIA NODIFLORA; LYMPHOCYTE PROLIFERATION; MOLECULAR DYNAMICS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BASOPHILS; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOKINES; DITERPENES; HUMANS; INFLAMMATION MEDIATORS; LEUKOCYTES, MONONUCLEAR; LIPPIA; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; NF-KAPPA B; RATS;

EID: 77956626058     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2010.493190     Document Type: Article

References (53)

1. Aggarwal, B. B. (2003). Signalling pathways of the TNF superfamily: a double edged sword. Nat. Rev. Immunol. 9:745-756.
2. Ajizian, S. J., English, B. K., Meals, E. A. (1999). Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma. J. Infect. Dis. 179:939-944.
3. Akihisa, T., Yasukawa, K. (2001). Antitumor-promoting and anti-inflammatory activities of triterpenoids and sterols from plants and fungi. In Stud. Nat. Prod. Chem. 25:43-87.
4. Baldwin, A. (2001). The transcription factor NF-kB and human disease. J. Clin. Invest. 107:3-6.
5. Baldwin, A. S. (1996). The NF-kB and IkB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-681.
6. Barkett, M., Gilmore, T. D. (1999). Control of apoptosis by Rel/NFkB transcription factors. Oncogene 18:6910-6924.
7. Bogdan, C., Rollinghoff, M., Diefenbach, A. (2000). Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol. 12:64-76.
8. Bonizzi, G., Karin, M. (2004). The two NFkB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25:280-288.
9. Clancy, R. M., Amin, A. R., Abramson, S. B. (1998). The role of nitric oxide in inflammation and immunity. Arthritis Rheum. 41:1141-1151.
10. Clark J. D., Lin L. L., Kriz R. W., Ramesha C. S., Sultzman L. A., Lin A. Y., et al. (1991). A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-depen-dent translocation domain with homology to PKC and GAP. Cell 65: 1043-1051.
11. Corcoran, M. L., Stetler-Stevenson, W. G., DeWitt, D. L., Wahl, L. M. (1994). Effect of cholera toxin and pertussis toxin on prostaglandin H synthase-2, prostaglandin E2, and matrix metallo proteinases production by human monocytes. Arch. Biochem. Biophys. 310:481-488.
12. Dignam, J. D., Martin, P. L. (1983). Eukaryotic gene transcription with purified components. Meth. Enzymol. 101:582-598.
13. Dinarello, C. A. (2001). Proinflammatory cytokines. Chest 118:503-508.
14. Gerondakis, S., Grumont, R., Rourke, I., Grossmann, M. (1998). The regulation and roles of Rel/NF-reB transcription factors during lymphocyte activation. Curr. Opin. Immunol. 10:353-359.
15. Ghosh, S., May, M. J., Kopp, E. B. (1998). NF-kB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-260.
16. Giang, P. M., Son, P. T. (2002). Phytochemical study on Machilus odoratissima Nees, Lauraceae. J. Chem. 40: 185-188.
17. Han, Z., Boyle, D. L., Chang, L., Bennett, B., Karin, M., Yang, L., et al. (2001). c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J. Clin. Invest. 108:73-81.
18. Jander, S., Sitzer, M., Schumann, R., Schroeter, M., Siebler, M., Steinmetz, H., et al. (1998). Inflammation in high-grade carotid stenosis: a possible role for macrophages and T cells in plaque destabilization. Stroke 29:1625-1630.
19. Karin, M., Ben-Neriah, Y. (2000). Phosphorylation meets ubiquitination: the control of NFkB activity. Annu. Rev. Immunol. 18:621-663.
20. Kawata, R., Reddy, S. T., Wolner, B., Herschman, H. R. (1995). Prostaglandin synthase 1 and prostaglandin synthase 2 both participate in activation-induced prostaglan-din D2 production in mast cells. J. Immunol. 155:818-825.
21. Kim, J. Y., Jung, K. S., Jeong, H. G. (2004). Suppressive effects of the kahweol and caf-estol on cyclooxygenase-2 expression in macrophages. FEBS Lett. 569: 321-326.
22. Kyriakis, J. M., Avruch, J. (2001). Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81:807-869.
23. Lam, T., Ling, T., Chowdhury, C., Chao, T. H., Bahjat, F. R., Lloyd, G. K., et al. (2003). Synthesis of a novel family of diterpenes and their evaluation as anti-inflammatory agents. Bioorg. Med. Chem. Lett. 13:3217-3221.
24. Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., et al. (1994). A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739-742.
25. Lee, J. C., Young, P. R. (1996). Role of CSBP/p38/RK stress response kinase LPS and cytokine signaling mechanisms. J. Leukoc. Biol. 59:152-157.
26. Lhousseine, T., Mounia A. (2001). Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases. Curr. Mol. Med. 1:739-754.
27. Manjula, N., Gayathri, B., Vinay kumar. K. S., Lakshmi, B. S., Balakrishnan, A. (2006). Inhibition of MAP kinases by crude extract and pure compound isolated from Commiphora mukul leads to down regulation of TNF-, IL-1beta and IL-2. Int. Immunopharmacol. 6:122-132.
28. Marshall, S. J., McCurdy, J. D., Olynych, T. (2003). Toll-like receptor-mediated activation of mast cells: Implications for allergic disease? Inter. Arch. Allergy Immunol. 132:87-97.
29. Means, T. K., Pavlovich, R. P., Roca, D., Vermeulen, M. W., Fenton, M. J. (2000). Activation of TNF- transcription utilizes distinct MAP kinase pathways in different macrophage populations. J. Leuk. Biol. 67:885-893.
30. Miagkov, A. V., Brown, C. E. (1998). NFkB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc. Natl. Acad. Sci USA 95:859-864.
31. Murphy, M. P. (1999). Nitric oxide and cell death. Biochim. Biophys. Acta 1411:401-414.
32. Nduagu, C., Ekefan, E. J., Nwankiti, A. O. (2008). Effect of some crude plant extracts on growth of Colletotrichum capsici (synd) Butler and Bisby, casual agent of pepper anthracnose. J. Appl. Biosci. 6(2):184-190.
33. Nisbet, L. J., Moore, M. (1997). Will natural products remain an important source of drug research for the future? Curr. Opin. Biotechnol. 8:708-712.
34. Pahl, H. L. (1999). Activators and target genes of Rel/NFk.B transcription factors. Oncogene 18:6853-6866.
35. Pearson, G., Robinson, F., Beers Gibson, T., Xu, B., Karandikar, M., Berman, K., et al. (2001). Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22:153-183.
36. Perkins, D. J., St Clair, E. W., Misukonis, M. A., Weinberg, J. B. (1998). Reduction of NOS2 overexpression in rheumatoid arthritis patients treated with anti-tumor necrosis factor alpha monoclonal antibody (cA2). Arthritis Rheum. 41:2205-2210.
37. Podolsky, D. K. (1991). Inflammatory bowel disease. N. Engl. J. Med. 325:928-937.
38. Raingeaud, J., Whitmarsh, A. J., Barrett, T., Derijard, B., Davis, R. J. (1996). MKK3-and MKK6-regulated gene expression is mediated by the p38 mitogen activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16:1247-1255.
39. Raso, G. M., Meli, R., Di Carlo, G., Pacilio, M., Di Carlo, R. (2001). Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A1. Life Sci. 68:921-931.
40. Ridker, P. M., Hennekens, C. H., Buring, J. E., Rifai, N. (2000). C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342:836-843. (Pubitemid 30165206)
41. Rios, M. Y., Aguilar-Guadarrama, A. B., Navarro, V. (2003). Two new benzofuranes from Eupatorium ascenbornianum and their anti-microbial activity. Planta Med. 69(10):967-970.
42. Shukla, S., Patel, R., Kukkar, R. (2009). Study of phytochemical and diuretic potential of methanol and aqueous extracts of aerial parts of Phyla nodiflora LINN. Int. J. Pharm. Pharm. Sci. 1(1):85-91.
43. Sharp, J. D., White, D. L., Chiou, X. G., Goodson, T., Gamboa, G. C., McClure, D., et al. (1991). Molecular cloning and expression of human Ca(2+)-sensitive cytosolic phospholipase A2. J. Biol. Chem. 266:14850-14853.
44. Southey, A., Tanaka, S., Murakami, T., Miyoshi, H., Ishizuka, T., Seqiura, M., et al. (1997). Pathophysiological role of nitric oxide in rat experimental colitis. Int. J. Immunopharmacol. 19:669-676. (Pubitemid 28270801)
45. Susanne, G., Thiericke, R. (1999). Bioactive agents from natural sources: trends in discovery and application. Adv. Biochem. Eng./Biotechnol. 64:101-154.
46. Swantek, J. L., Cobb, M. H., Geppert, T. D. (1997). Jun N-terminal kinase/stress-acti-vated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-a) translation: glucocorticoids inhibit TNF- translation by blocking JNK/SAPK. Mol. Cell Biol. 17:6274-6282.
47. Tak, P. P., Firestein, G. S. (2001). NF-kB: a key role in inflammatory diseases. J. Clin. Invest. 107:7-11.
48. Thiericke, R. (2000). Drug discovery from nature: automated high-quality sample preparation. J. Autom. Meth. Mgmt. Chem. 22:149-157.
49. Valero, R., Baron, M. L., Guerin, S., Beliard, S., Lelouard, H., Kahn-Perles, B., et al. (2002). A defective NFkB/RelB pathway in Auto immuneprone New Zealand Black Mice is associated with inefficient expansion of Thymocyte and Dendritic cells. J. Immunol. 169:185-192.
50. Van der Bruggen, T., Nijenhuis, S., van Raaij, E., Verhoef, J., van Asbeck, B. S. (1999). Lipopolysaccharide-induced tumor necrosis factor alpha production by human monocytes involves the raf-1/MEK1-MEK2/ERK1-ERK2 pathway. Infect. Immun. 67:3824-3829.
51. Van der Wal A. C., Becker A. E., van der Loos C. M., Das P. K. (1994). Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89:36-44.
52. Vincenti, M. P., Brinckerhoff, C. E. (2001). The potential of signal transduction inhibitors for the treatment of arthritis: Is it all just JNK? J. Clin. Invest. 108:181-183.
53. Welgus, H. G., Campbell, E. J., Curry, J. D., Aisen, A. Z., Senior, R. M., Wilhelm, S. M., et al. (1990). Neutral metalloproteinases produced by human mononuclear phagocytes: enzyme profile, regulation and cellular differentiation. J. Clin. Invest. 86: 1496-1502.